MEI Pharma, Inc. MEIP was a big mover last session with its shares rising over 5% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the volatile price range of $1.54 to $1.73 in the past five trading sessions.
This developer of oncology drugs has seen two positive estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
MEI Pharma currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Investors interested in the Med-Drugs space may also consider Corcept Therapeutics Inc. CORT, which holds a Zacks Rank #1 (Strong Buy).
Is MEIP going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment